2-methylpentane has been researched along with Sarcoma, Ewing in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asrari, F; Attawia, MA; Borden, MD; Herbert, KM; Katti, DS; Laurencin, CT; Uhrich, KE | 1 |
1 other study(ies) available for 2-methylpentane and Sarcoma, Ewing
Article | Year |
---|---|
Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system.
Topics: Antineoplastic Agents, Phytogenic; Biocompatible Materials; Bone Neoplasms; Cell Cycle; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Delivery Systems; Flow Cytometry; Hexanes; Humans; Microscopy, Electron, Scanning; Microspheres; Paclitaxel; Particle Size; Polymers; Radiation-Sensitizing Agents; Sarcoma, Ewing; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2001 |